LLMs in Disease Diagnosis: A Comparative Study of DeepSeek-R1 and O3 Mini Across Chronic Health Conditions (2503.10486v2)

Abstract: LLMs are revolutionizing medical diagnostics by enhancing both disease classification and clinical decision-making. In this study, we evaluate the performance of two LLM- based diagnostic tools, DeepSeek R1 and O3 Mini, using a structured dataset of symptoms and diagnoses. We assessed their predictive accuracy at both the disease and category levels, as well as the reliability of their confidence scores. DeepSeek R1 achieved a disease-level accuracy of 76% and an overall accuracy of 82%, outperforming O3 Mini, which attained 72% and 75% respectively. Notably, DeepSeek R1 demonstrated exceptional performance in Mental Health, Neurological Disorders, and Oncology, where it reached 100% accuracy, while O3 Mini excelled in Autoimmune Disease classification with 100% accuracy. Both models, however, struggled with Respiratory Disease classification, recording accuracies of only 40% for DeepSeek R1 and 20% for O3 Mini. Additionally, the analysis of confidence scores revealed that DeepSeek R1 provided high-confidence predictions in 92% of cases, compared to 68% for O3 Mini. Ethical considerations regarding bias, model interpretability, and data privacy are also discussed to ensure the responsible integration of LLMs into clinical practice. Overall, our findings offer valuable insights into the strengths and limitations of LLM-based diagnostic systems and provide a roadmap for future enhancements in AI-driven healthcare.